Results 71 to 80 of about 50,863 (305)

Caracterització de la sinovitis mitjançant mètodes artroscòpics i immunohistoquímics. Valor diagnòstic i pronòstic [PDF]

, 2006
[cat] La membrana sinovial, és el lloc on s'inicia i es perpetua el procés inflamatori que caracteritza a les diferents artropaties inflamatòries. A diferència d'altres òrgans no té una estructura definida, motiu pel qual el context on es produeix la ...
Salvador Alarcón, Georgina
core  

Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis [PDF]

, 2023
Given the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD), a session was devoted at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting to discussing the ...
Suzanne Grieb, Grieb, Suzanne, Philip J. Mease, Chandran, Vinod, Vinod Chandran, Mease, Philip J, Peter Nash, Nash, Peter   +7 more
core   +1 more source

Psoriatic arthritis: a review [PDF]

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
SummaryPsoriatic arthritis (PsA) is an immunologically triggered, chronic inflammatory arthropathy, which can have a lasting influence on the quality of life of affected individuals. An early diagnosis is essential in order to institute adequate therapy.
Anne, Amherd-Hoekstra, Helmut, Näher, Hanns-Martin, Lorenz, Alexander H, Enk   +3 more
openaire   +2 more sources

Associations of Lifestyle‐Related Factors and Psoriatic Arthritis Disease Activity: The Dutch South West Psoriatic Arthritis Study

Arthritis Care &Research, EarlyView.
Objective This study aims to investigate lifestyle‐related factors in patients with psoriatic arthritis (PsA) and their association with disease activity measurements. Methods This multicenter cohort included 938 patients who were newly diagnosed with PsA between 2013 and 2023.
Batoul Hojeij, Ilja Tchetverikov, Marc R. Kok, Marijn Vis, Yvonne Goekoop‐Ruiterman, Jessica Bijsterbosch, Paul Baudoin, Reinhard Bos, Jos H. van der Kaap, Petra Kok, Lindy‐Anne Korswagen, Jolanda J. Luime   +11 more
wiley   +1 more source

Translational perspectives on psoriatic arthritis. [PDF]

, 2009
The term psoriatic disease encompasses the array of disorders (arthritis, inflammatory bowel disease, uveitis, obesity, metabolic syndrome, type II diabetes, and cardiovascular disease) that are associated with psoriasis.
Proulx, Steven T, Ritchlin, Christopher T, Schwarz, Edward S   +2 more
core   +1 more source

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS

Медицинская иммунология, 2019
Psoriatic arthritis is a chronic progressive systemic inflammatory disease of joints and spine, which leads to the development of erosive arthritis, bone resorbtion, multiple enthesitis and spondylitis. Severe clinical course, resistance to therapy, high
A. A. Barilo, S. V. Smirnova, M. V. Smolnikova   +2 more
doaj   +1 more source

Linking the effect of psoriatic arthritis-related foot involvement to the Leeds Foot Impact Scale using the International Classification for Functioning, Disability and Health: a study to assess content validity

Journal of Foot and Ankle Research, 2020
Background Previous research to describe the impact of foot involvement in psoriatic arthritis has used the Leeds Foot Impact Scale in Rheumatoid Arthritis (LFIS-RA) in the current absence of any psoriatic arthritis foot-specific tools. However, the LFIS-
Kate Carter, Caterina Tannous, Steven Walmsley, Keith Rome, Deborah E. Turner   +4 more
doaj   +1 more source

Methotrexate for psoriatic arthritis [PDF]

Cochrane Database of Systematic Reviews, 2017
Psoriatic arthritis is an inflammatory disease associated with joint damage, impaired function, pain, and reduced quality of life. Methotrexate is a disease-modifying anti-rheumatic drug (DMARD) commonly prescribed to alleviate symptoms, attenuate disease activity, and prevent progression of disease.To assess the benefits and harms of methotrexate for ...
Tom D, Wilsdon, Samuel L, Whittle, Tilenka Rj, Thynne, Arduino A, Mangoni   +3 more
openaire   +3 more sources

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

Arthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source

Challenges of biological therapy in patients with pustular psoriasis coexisting with psoriatic arthritis [PDF]

, 2017
Introduction . Psoriasis is a chronic inflammatory skin disease affecting approximately 2–3% of the general population. It is a condition with immunological and genetic background, coexisting with psoriatic arthritis in about 25% of cases. Biologic drugs
Joanna Narbutt, Magdalena Trelińska, Anna Woźniacka, Irmina Olejniczak-Staruch, Aleksandra Lesiak   +4 more
core   +1 more source